Predictions
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Pluristem Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.41
27.12.21
27.12.21
€2.50
27.12.22
27.12.22
-31.19%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.97
27.12.21
27.12.21
€6.00
27.12.22
27.12.22
-83.85%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€7.34
26.12.21
26.12.21
€10.00
26.12.22
26.12.22
10.35%
25.09.22
25.09.22
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Eurobio scientific
Start price
Target price
Perf. (%)
€28.54
26.12.21
26.12.21
-
26.12.22
26.12.22
-32.45%
14.03.22
14.03.22
Could be worthwhile Investment >10% per year
Radius Health Inc.
Start price
Target price
Perf. (%)
€6.35
26.12.21
26.12.21
-
26.12.22
26.12.22
-7.81%
09.01.22
09.01.22
Risky Investment
Pfizer Inc.
Start price
Target price
Perf. (%)
€52.51
22.12.21
22.12.21
€55.00
22.12.22
22.12.22
-7.45%
23.12.22
23.12.22
Could be worthwhile Investment >10% per year
CEL-SCI Corp.
Start price
Target price
Perf. (%)
€7.12
22.12.21
22.12.21
€8.00
22.12.22
22.12.22
-71.18%
23.12.22
23.12.22
Could be worthwhile Investment >10% per year
BiondVax Pharmaceuticals Ltd ADR
Start price
Target price
Perf. (%)
€24.60
22.12.21
22.12.21
-
22.12.22
22.12.22
-15.45%
25.12.21
25.12.21
Risky Investment
Johnson & Johnson
Start price
Target price
Perf. (%)
€147.94
22.12.21
22.12.21
-
22.12.25
22.12.25
1.31%
28.12.21
28.12.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€3.49
21.12.21
21.12.21
-
21.12.22
21.12.22
7.56%
25.12.21
25.12.21
Risky Investment
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.41
20.12.21
20.12.21
€7.20
20.12.22
20.12.22
-15.91%
30.01.22
30.01.22
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.88
20.12.21
20.12.21
€1.20
20.12.22
20.12.22
-25.64%
09.01.22
09.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Novavax Inc.
Start price
Target price
Perf. (%)
€183.96
17.12.21
17.12.21
€240.00
17.12.22
17.12.22
-37.46%
10.01.22
10.01.22
Could be worthwhile Investment >10% per year
Some uniques
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€32.60
16.12.21
16.12.21
-
16.12.22
16.12.22
38.19%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Evotec SE ADR
Start price
Target price
Perf. (%)
€21.40
16.12.21
16.12.21
-
16.12.25
16.12.25
-60.75%
12.01.24
12.01.24
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€24.64
16.12.21
16.12.21
€33.00
31.12.23
31.12.23
-67.02%
07.09.22
07.09.22
Could be very worthwhile Investment >20% year
MagForce AG
Start price
Target price
Perf. (%)
€2.87
15.12.21
15.12.21
-
15.12.22
15.12.22
-99.93%
16.12.22
16.12.22
Revenue growth >5% per year expected
Probably not worthwhile Investment
High valuation
Risky balance sheet
Sanofi S.A.
Start price
Target price
Perf. (%)
€85.57
14.12.21
14.12.21
€124.00
14.12.22
14.12.22
5.18%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year